Skip to main content
Top
Published in: Rheumatology International 5/2012

01-05-2012 | Short Communication

Atypical presentation of Behçet’s disease with central nervous system involvement successfully treated with infliximab

Authors: U. Studer, B. Ruehe, G. Waldegg, I. Vajtai, R. Escher, D. Aeberli

Published in: Rheumatology International | Issue 5/2012

Login to get access

Abstract

Central nervous system involvement is a rare and serious complication of Behçet’s disease (BD). Herein, we describe a patient with an atypical central lesion, who experienced progressive hypesthesia of the right arm and sensory loss of the trigeminal nerve together with intense headache. A repeated biopsy was necessary to conclusively establish the diagnosis of BD. Therapy with infusions of infliximab led to a remarkable full remission. TNFα-blocking therapy was successfully replaced by azathioprine. The present well-illustrated case demonstrates the difficulty of establishing the diagnosis of BD with central nervous system involvement, the dramatic benefit of short given TNF-α-blocking agent, and the long-term remission with azathioprin.
Literature
1.
go back to reference Behçet H (1937) Über rezidivierende, aphtöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatologische Wochenschr 105(36):1152–1163 Behçet H (1937) Über rezidivierende, aphtöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatologische Wochenschr 105(36):1152–1163
2.
go back to reference Marshall SE (2004) Behcet’s disease. Best Pract Res Clin Rheumatol 18(3):291–311PubMed Marshall SE (2004) Behcet’s disease. Best Pract Res Clin Rheumatol 18(3):291–311PubMed
3.
go back to reference Criteria for diagnosis of Behcet’s disease (1990) International study group for Behcet’s disease. Lancet 335(8697):1078–1080 Criteria for diagnosis of Behcet’s disease (1990) International study group for Behcet’s disease. Lancet 335(8697):1078–1080
4.
go back to reference Hamuryudan V et al (1997) Azathioprine in Behcet’s syndrome: effects on long-term prognosis. Arthritis Rheum 40(4):769–774PubMedCrossRef Hamuryudan V et al (1997) Azathioprine in Behcet’s syndrome: effects on long-term prognosis. Arthritis Rheum 40(4):769–774PubMedCrossRef
5.
go back to reference Pipitone N et al (2008) Infliximab for the treatment of Neuro-Behcet’s disease: a case series and review of the literature. Arthritis Rheum 59(2):285–290PubMedCrossRef Pipitone N et al (2008) Infliximab for the treatment of Neuro-Behcet’s disease: a case series and review of the literature. Arthritis Rheum 59(2):285–290PubMedCrossRef
6.
go back to reference Serdaroglu P et al (1989) Neurologic involvement in Behcet’s syndrome. A prospective study. Arch Neurol 46(3):265–269PubMedCrossRef Serdaroglu P et al (1989) Neurologic involvement in Behcet’s syndrome. A prospective study. Arch Neurol 46(3):265–269PubMedCrossRef
7.
go back to reference Ashjazadeh N et al (2003) Neuro-Behcet’s disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behcet’s disease in 96 Iranian patients. Exp Mol Pathol 74(1):17–22PubMedCrossRef Ashjazadeh N et al (2003) Neuro-Behcet’s disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behcet’s disease in 96 Iranian patients. Exp Mol Pathol 74(1):17–22PubMedCrossRef
8.
go back to reference Lannuzel A et al (2002) Neurological manifestations of Behcet’s disease in a Caribbean population: clinical and imaging findings. J Neurol 249(4):410–418PubMedCrossRef Lannuzel A et al (2002) Neurological manifestations of Behcet’s disease in a Caribbean population: clinical and imaging findings. J Neurol 249(4):410–418PubMedCrossRef
9.
go back to reference Siva A, Saip S (2009) The spectrum of nervous system involvement in Behcet’s syndrome and its differential diagnosis. J Neurol 256(4):513–529PubMedCrossRef Siva A, Saip S (2009) The spectrum of nervous system involvement in Behcet’s syndrome and its differential diagnosis. J Neurol 256(4):513–529PubMedCrossRef
10.
go back to reference Al-Araji A, Kidd DP (2009) Neuro-Behcet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8(2):192–204PubMedCrossRef Al-Araji A, Kidd DP (2009) Neuro-Behcet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol 8(2):192–204PubMedCrossRef
11.
go back to reference Heo JH et al (2008) Neuro-Behcet’s disease mimicking multiple brain tumors: diffusion-weighted MR study and literature review. J Neurol Sci 264(1–2):177–181PubMedCrossRef Heo JH et al (2008) Neuro-Behcet’s disease mimicking multiple brain tumors: diffusion-weighted MR study and literature review. J Neurol Sci 264(1–2):177–181PubMedCrossRef
Metadata
Title
Atypical presentation of Behçet’s disease with central nervous system involvement successfully treated with infliximab
Authors
U. Studer
B. Ruehe
G. Waldegg
I. Vajtai
R. Escher
D. Aeberli
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1915-x

Other articles of this Issue 5/2012

Rheumatology International 5/2012 Go to the issue